Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions

Journal of Diabetes Science and Technology

Volumn 9, Issue 6, 2015, Pages 1282-1291

  McVey, Elaine ^a,b   Keith, Steven ^a,c   Herr, Joshua K ^a   Sutter, Diane ^a   Pettis, Ronald J ^a  

^a BD Technologies   (United States)

^b Maxpoint Interactive   (United States)

^c PARKER HANNIFIN CORPORATION   (United States)

Author keywords

continuous subcutaneous insulin delivery; insulin infusion catheter sets; insulin pump occlusion; intradermal insulin delivery; silent occlusion

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADOLESCENT; ADULT; ADVERSE EFFECTS; ALARM MONITOR; ALGORITHM; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE FAILURE; EQUIPMENT DESIGN; FEASIBILITY STUDY; FEMALE; HUMAN; INSULIN INFUSION; MALE; MATERIALS TESTING; MIDDLE AGED; NEEDLE; NORMAL HUMAN; PRESSURE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ALGORITHMS; CLINICAL ALARMS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEASIBILITY STUDIES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MATERIALS TESTING; MIDDLE AGED; NEEDLES; PRESSURE; TIME FACTORS; YOUNG ADULT;

EID: 84990957411     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296815598327     Document Type: Article

References (27)

1. Gupta J, Felner EI, Prausnitz MR. Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther. 2011;13(4):451-456.
2. McVey E, Hirsch L, Sutter DE, et al. Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion. J Diabetes Sci Technol. 2012;6(4):743-754.
3. Pettis RJ, Ginsberg B, Hirsch L, et al. Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther. 2011;13(4):435-442.
4. Pettis RJ, Hirsch L, Kapitza C, et al. Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther. 2011;13(4):443-450.
5. van Bon AC, Dragt D, DeVries JH. Significant time until catheter occlusion alerts in currently marketed insulin pumps at two basal rates. Diabetes Technol Ther. 2012;14(5): 447-448.
6. van Bon AC, Bode BW, Sert-Langeron C, DeVries JH, Charpentier G. Insulin glulisine compared to insulin aspart and to insulin lispro administered by continuous subcutaneous insulin infusion in patients with type 1 diabetes: a randomized controlled trial. Diabetes Technol Ther. 2011;13(6):607-614.
7. Patel PJ, Benasi K, Ferrari G, et al. Randomized trial of infusion set function: steel versus Teflon. Diabetes Technol Ther. 2014;16(1):15-19.
8. Brunton S. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med. 2008;121(6 suppl):S35-S41.
9. Heinemann L, Krinelke L. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol. 2012;6(4):954-964.
10. Zhang Y, Jetley R, Jones PL, Ray A. Generic safety requirements for developing safe insulin pump software. J Diabetes Sci Technol. 2011;5(6):1403-1419.
11. Zhang Y, Jones PL, Klonoff DC. Second insulin pump safety meeting: summary report. J Diabetes Sci Technol. 2010;4(2):488-493.
12. Keith S, McVey E, Pettis RJ. High sensitivity occlusion detection using fluid pressure monitoring during basal insulin infusion. Diabetes. 2013;62 (suppl 1):A249-A250.
13. Laurent PE, Pettis R, Easterbrook W, Berube J. Evaluating new hypodermic and intradermal injection devices. Med Device Technol. 2006;17(2):16-19.
14. US Patent Application. 20140107613. System and method for detecting occlusions in a medication infusion system using pulsewise pressure signals.
15. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009;333:369-393.
16. Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol. 2011;7(7):385-395.
17. Peyser T, Dassau E, Breton M, Skyler JS. The artificial pancreas: current status and future prospects in the management of diabetes. Ann NY Acad Sci. 2014;1311:102-123.
18. McCall AL, Farhy LS. Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control. Minerva Endocrinol. 2013;38(2):145-163.
19. Shetty G, Wolpert H. Insulin pump use in adults with type 1 diabetes—practical issues. Diabetes Technol Ther. 2010; 12(suppl 1):S11-S16.
20. American Association of Diabetes Educators. Insulin pump therapy: Best practices in choosing and using infusion devices. 2011.
21. Kerr D, Morton J, Whately-Smith C, Everett J, Begley JP. Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates. J Diabetes Sci Technol. 2008;2(3):450-455.
22. Ponder SW, Skyler JS, Kruger DF, Matheson D, Brown BW. Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment. Diabetes Educ. 2008;34(2):327-333.
23. Medtronic. Paradigm® REAL-Time Revel Insulin Pump MiniMed user guide. 2009.
24. Wadwa RP, Fiallo-Scharer R, Vanderwel B, Messer LH, Cobry E, Chase HP. Continuous glucose monitoring in youth with type 1 diabetes. Diabetes Technol Ther. 2009;11(suppl 1):S83-S91.
25. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care. 2007;30(5):1125-1130.
26. Cameron F, Buckingham BA, Wilson DM, Bequette BW. Extending threshold-based detection of infusion set failures. J Diabetes Sci Technol. 2012;7(1):A17.
27. Bequette BW. Challenges and recent progress in the development of a closed-loop artificial pancreas. Annu Rev Control. 2012;36(2):255-266.